Fredric E. Wondisford - Publications

University of Chicago, Chicago, IL 
Molecular Biology, Nutrition

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 He L, Chang E, Peng J, An H, McMillin SM, Radovick S, Stratakis CA, Wondisford FE. Activation of the cAMP-PKA pathway antagonizes metformin suppression of hepatic glucose production. The Journal of Biological Chemistry. PMID 27002150 DOI: 10.1074/jbc.M116.719666  0.4
2015 Dadwal P, Mahmud N, Sinai L, Azimi A, Fatt M, Wondisford FE, Miller FD, Morshead CM. Activating Endogenous Neural Precursor Cells Using Metformin Leads to Neural Repair and Functional Recovery in a Model of Childhood Brain Injury. Stem Cell Reports. 5: 166-73. PMID 26235894 DOI: 10.1016/j.stemcr.2015.06.011  0.4
2015 Meng S, Cao J, He Q, Xiong L, Chang E, Radovick S, Wondisford FE, He L. Metformin activates AMP-activated protein kinase by promoting formation of the αβγ heterotrimeric complex. The Journal of Biological Chemistry. 290: 3793-802. PMID 25538235 DOI: 10.1074/jbc.M114.604421  0.4
2014 Tuttle RM, Wondisford FE. Welcome to the 84th annual meeting of the American Thyroid Association. Thyroid : Official Journal of the American Thyroid Association. 24: 1439-40. PMID 25229351 DOI: 10.1089/thy.2014.0429  0.4
2014 Cao J, Meng S, Chang E, Beckwith-Fickas K, Xiong L, Cole RN, Radovick S, Wondisford FE, He L. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK). The Journal of Biological Chemistry. 289: 20435-46. PMID 24928508 DOI: 10.1074/jbc.M114.567271  0.4
2011 Diaczok D, Divall S, Matsuo I, Wondisford FE, Wolfe AM, Radovick S. Deletion of Otx2 in GnRH neurons results in a mouse model of hypogonadotropic hypogonadism Molecular Endocrinology. 25: 833-846. PMID 21436260 DOI: 10.1210/me.2010-0271  0.4
2009 Singh SP, Wolfe A, Ng Y, DiVall SA, Buggs C, Levine JE, Wondisford FE, Radovick S. Impaired estrogen feedback and infertility in female mice with pituitary-specific deletion of estrogen receptor alpha (ESR1). Biology of Reproduction. 81: 488-96. PMID 19439729 DOI: 10.1095/biolreprod.108.075259  0.4
2009 Machado DS, Sabet A, Santiago LA, Sidhaye AR, Chiamolera MI, Ortiga-Carvalho TM, Wondisford FE. A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Proceedings of the National Academy of Sciences of the United States of America. 106: 9441-6. PMID 19439650 DOI: 10.1073/pnas.0903227106  0.4
2009 Alonso M, Goodwin C, Liao X, Ortiga-Carvalho T, Machado DS, Wondisford FE, Refetoff S, Weiss RE. In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice. Endocrinology. 150: 3927-34. PMID 19406944 DOI: 10.1210/en.2009-0093  0.4
2008 Pessôa CN, Santiago LA, Santiago DA, Machado DS, Rocha FA, Ventura DF, Hokoç JN, Pazos-Moura CC, Wondisford FE, Gardino PF, Ortiga-Carvalho TM. Thyroid hormone action is required for normal cone opsin expression during mouse retinal development. Investigative Ophthalmology & Visual Science. 49: 2039-45. PMID 18436838 DOI: 10.1167/iovs.07-0908  0.4
2008 Sinkevicius KW, Burdette JE, Woloszyn K, Hewitt SC, Hamilton K, Sugg SL, Temple KA, Wondisford FE, Korach KS, Woodruff TK, Greene GL. An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo. Endocrinology. 149: 2970-9. PMID 18339713 DOI: 10.1210/en.2007-1526  0.4
2006 Hussain MA, Porras DL, Rowe MH, West JR, Song WJ, Schreiber WE, Wondisford FE. Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation. Molecular and Cellular Biology. 26: 7747-59. PMID 16908541 DOI: 10.1128/MCB.02353-05  0.4
2006 Cohen RN, Brue T, Naik K, Houlihan CA, Wondisford FE, Radovick S. The role of CBP/p300 interactions and Pit-1 dimerization in the pathophysiological mechanism of combined pituitary hormone deficiency Journal of Clinical Endocrinology and Metabolism. 91: 239-247. PMID 16263824 DOI: 10.1210/jc.2005-1211  0.4
2006 Hashimoto K, Cohen RN, Yamada M, Markan KR, Monden T, Satoh T, Mori M, Wondisford FE. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model Journal of Biological Chemistry. 281: 295-302. PMID 16260782 DOI: 10.1074/jbc.M507877200  0.4
2005 Ortiga-Carvalho TM, Shibusawa N, Nikrodhanond A, Oliveira KJ, Machado DS, Liao XH, Cohen RN, Refetoff S, Wondisford FE. Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. The Journal of Clinical Investigation. 115: 2517-23. PMID 16100573 DOI: 10.1172/JCI24109  0.4
2005 Temple KA, Cohen RN, Wondisford SR, Yu C, Deplewski D, Wondisford FE. An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements. The Journal of Biological Chemistry. 280: 3529-40. PMID 15572375 DOI: 10.1074/jbc.M411422200  0.4
2003 Shibusawa N, Hashimoto K, Nikrodhanond AA, Liberman MC, Applebury ML, Liao XH, Robbins JT, Refetoff S, Cohen RN, Wondisford FE. Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo. The Journal of Clinical Investigation. 112: 588-97. PMID 12925699 DOI: 10.1172/JCI18377  0.4
Show low-probability matches.